Panadol Joint

Go To

Panadol Joint pack shot

Provides immediate release and pain relief up to 8 hours.1

The sustained release tablet with bi-layer technology releases drug at a rate which ensures therapeutically active plasma paracetamol concentrations are rapidly attained and maintained until up to 8 hours after administration.1

Bi-layer technology

Graph showing average changes in pain scores between paracetamol and celecoxib. Adapted by Geba 2002.

Panadol Joint is used in treatment of joint pain arising from osteoarthritis.1

Paracetamol topical NSAIDs

Paracetamol and/or topical NSAIDs should be considered ahead of oral NSAIDs, COX-2 inhibitors or opioids.2

What can Panadol Joint do for Robert?

Image of a patient with knee pain

Robert needs pain relief for osteoarthritis

Robert was an athlete when he was younger. As the years progressed he developed persistent knee pain and was diagnosed as having right-knee osteoarthritis. He’s already on other medications for his hypertension and diabetes but really needs help to ease his pain. He tries staying active by going for walks and gardening but some days it is a struggle. Robert wishes he could go back to being active again.

Panadol Joint with its bi-layer technology can offer Robert sustained pain relief for up to 8 hours. Containing paracetamol, it is also gentler compared to other prescription pain medications.

Recommend Panadol Joint for fast and sustained relief

Panadol Joint pack shot

Panadol Joint

A Unique Bi-layer tablet incorporating an immediate release & sustained release dose of paracetamol.1

Panadol Joint product details

  • Each extended release tablet contains:1Paracetamol 665mg

    Inactive ingredients:Sustained release layer: Hypromellose, povidone, pregelatinised starch, Magensium stearate, immediate release layer, pregelatinised starch, croscarmellose sodium, povidone, stearic acid

    Film coat: Hypromellose, Glycerol triacetate

    Wax coating: Carnauba wax

  • Warning and precautions:1

    Underlying liver disease increases the risk of paracetamol-related liver damage patients who have been diagnosed with liver or kidney impairment mush seek medical advice before taking this medication.Please see your doctor if your symptoms do not improve.If symptoms persist medical advice should be sought.Keep out of sight and reach of children.

    Ability to perform tasks that require judgment, motor or cognitive skills:

    No significant effect.

    Unlikely to cause an effect on ability to drive and use machines.

    Pregnancy and lactation:

    Human and animal studies with paracetamol have not been identified any risk to pregnancy or embryo-fetal development.

    Lactation: Human studies with paracetamol have not identified any risk to lactation or the breast-fed offspring. Paracetamol crosses the placental barrier and is excreted in breast milk but not in clinically significant amount.

    As with any medication, medical advice should be sought before using this product in pregnancy.

  • Body system

    Undesirable effect

    		 Frequency

    Blood and lymphatic system disorders

    		 Thrombocytopenia very rare

    Immune system disorders

    Anaphylaxis

    Cutaneous hypersensitivity reactions including, among others, skin rashes, angioedema and Steven Johnson syndrome and toxic epidermal necrolysis

    		 very rare

    Respiratory, thoracic and mediastinal disorders

    Bronchospasm in patients sensitive to aspirin and other NSAIDs

    		 very rare

    Hepatobiliary disorders

    Hepatic dysfunction

    		 very rare

Learn more

Panadol Joint caplet disintegrating

Bi-layer technology

Discover more about this revolutionary patented technology that allows delivery of extended release paracetamol when it is needed most.

Discover more

Patient consulting with a pharmacist

Osteoarthritis care guide

Specially tailored for pharmacists, this tool helps you manage your patient’s osteoarthritic pain needs efficiently.

Get it now

Woman with migraine

Learning Lab

Discover the science behind our Innovation.

Read more